Skip to content

Leadership Team

Catheter Precision is led by a dedicated team with industry knowledge and overseen by a board of directors with decades of experience and proven track records. 

Executive Management

David Jenkins

Chief Executive Officer

David Jenkins has been in the medical device field for over thirty years, all with small companies. In addition to Catheter Precision, Inc., he has previously operated two other cardiac electrophysiology companies, as CEO and Chairman: Arrhythmia Research Technology, Inc., and EP MedSystems, Inc. In addition, he founded Transneuronix, Inc., a company in the implantable neurostimulator market, focused on obesity and weight loss. He began his career as a CPA with Coopers and Lybrand in Austin Texas.

Mr. Jenkins holds a BS degree in accounting from the University of Kansas, and a master’s in public accounting degree from the University of Texas at Austin.

Margrit Thomassen

Interim Chief Financial Officer

Margrit holds a Bachelors of Science in Accounting from Rider University and a Masters of Business Administration in Finance from Farleigh Dickinson University and is a licensed Certified Public Accountant. She spent 10 years in public accounting and then moved to an internal audit group with a large publicly held utility. After 2 years, she joined Transneuronix as the controller and was with that company through the acquisition by Medtronic in 2005. From 2005 until 2023 she has worked as CFO of SeaCap Management LLC on various investment opportunities handling accounting, tax, management and human resources tasks. In 2021 she assumed the role of Controller at Catheter Precision.

Marie-Claude Jacques

Chief Commercialization Officer

Marie-Claude Jacques has been a part of the medical device field for over 15 years. Prior to her time at Boston Scientific, she began her career with Baylis Medical and was an integral part in growing and scaling the sales US business. Mrs. Jacques led the company to double digit sales growth for consecutive years and participated in market development which led to the acquisition by Boston Scientific in 2022.

Marie-Claude has a bachelor’s degree in microbiology from Université Laval and a Master’s degree in Business Administration from University of Warwick.

Missiaen Huck

Chief Operating Officer

Ms. Huck has been in the medical device field since 2009. Initially she began her career in marketing but has since held management positions in multiple roles including clinical, regulatory and quality and manufacturing/operations, giving her a unique understanding of several departments.

Ms. Huck holds a bachelor’s degree in Journalism and Communications from the University of South Carolina.